Table 2. Prognostic effect of the ratio of nuclear to cytoplasmic FOXP3+CD4+ cells, adjusted for baseline characteristics.
#Adjusted effect of %nFOXP3+/cFOXP3+ | Covariate effect | |||||
Model covariate | OR | 95% CI | p-value | OR | 95% CI | p-value |
Age a surgery: ≥64 vs ≤63 years | 9.2 | (1.7 to 48.9) | 0.009 | 5.4 | (0.5 to 62.9) | 0.178 |
Gender: female vs male | 8.4 | (2.0 to 35.5) | 0.004 | 4.7 | (0.5 to 49.2) | 0.194 |
Race: Hispanic vs white nonHispanic | 6.3 | (1.9 to 20.5) | 0.003 | 0.7 | (0.1 to 6.8) | 0.739 |
Current or former use of tobacco and alcohol: | 7.2 | (1.9 to 27.2) | 0.004 | – | – | – |
Tobacco only | – | – | – | 0.2 | (0.01 to 5.2) | 0.301 |
Alcohol only | – | – | – | 1.0 | (0.0 to 478.2) | 0.989 |
both | – | – | – | 0.3 | (0.02 to 5.0) | 0.429 |
T-stage: T-2 vs T-1 | 8.2 | (2.2 to 30.9) | 0.002 | 9.1 | (0.7 to 124.5) | 0.097 |
Grade: mod/poor differentiation v well differentiated | 6.5 | (1.9 to 21.8) | 0.002 | 4.2 | (0.5 to 35.5) | 0.193 |
OR: Odds ratio. CI: Confidence interval. p-value:Wald test.
Risk of recurrence per twofold increase in ratio of nuclear to cytoplasmic FOXP3+CD4+ cells, adjusted for covariate shown at left.